SCHEMBL976764

SCHEMBL976764

C=CC[C@@H](O)CC(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 6/20 0.37
HSD17B10 Q99714 1/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
RECQL P46063 1/20 0.32
POLB P06746 1/20 0.31
POLA1 P09884 1/20 0.31
RAB9A P51151 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18076264 1.00 ALDH1A1 (0.46) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL8136448 0.81 TSHR (0.39) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL2592556 0.81 TSHR (0.39) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL24438525 0.80 ALDH1A1 (0.47) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL12925787 0.80 GAA (0.41) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL14209811 0.80 LMNA (0.40) ALDH1A1LMNATSHRCYP3A4CYP2C19
SCHEMBL28243 0.79 TSHR (0.50) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL11361190 0.79 CA1 (0.35) TSHRCYP3A4CYP2C19
SCHEMBL3186126 0.79 ALDH1A1 (0.46) ALDH1A1LMNATSHRHSD17B10MGAM
SCHEMBL374306 0.79 ALDH1A1 (0.46) ALDH1A1LMNATSHRHSD17B10MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109810090-A One kind (3R, 9R) -3- hydroxyl -7- oxo -9- methyl decalactone and preparation method thereof 绍兴文理学院 2019-05-28 CN claimed
US-11913055-B2 Continuous flow method for preparing (R)-3-hydroxy-5-hexenoate FUDAN UNIVERSITY (CN) 2024-02-27 US disclosed
US-20220033863-A1 CONTINUOUS FLOW METHOD FOR PREPARING (R)-3-HYDROXY-5-HEXENOATE FUDAN UNIVERSITY (CN) 2022-02-03 US disclosed
CN-108359626-B Engineering bacterium and application thereof in preparation of (R) -3-hydroxy-5-hexenoic acid ester 复旦大学 2021-10-26 CN disclosed
CN-111686809-A Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof 复旦大学 2020-09-22 CN disclosed
CN-109810090-A One kind (3R, 9R) -3- hydroxyl -7- oxo -9- methyl decalactone and preparation method thereof 绍兴文理学院 2019-05-28 CN disclosed
CN-108359626-A It a kind of engineering bacteria and its is preparing(R)Application in -3- hydroxyl -5- hexene acid esters 复旦大学 2018-08-03 CN disclosed
US-9932361-B2 Convenient process for the preparation of statins F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2018-04-03 US disclosed
EP-2867231-B1 CONVENIENT PROCESS FOR THE PREPARATION OF STATINS F I S - FABBRICA ITALIANA SINTETICI S P A (IT) 2017-01-04 EP disclosed
US-20160200744-A1 CONVENIENT PROCESS FOR THE PREPARATION OF STATINS F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2016-07-14 US disclosed
US-20150344439-A1 Convenient Process for the Preparation of Statins F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2015-12-03 US disclosed
US-20150344439-A1 Convenient Process for the Preparation of Statins F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2015-12-03 US disclosed
US-8933269-B2 Rosuvastatin calcium intermediate and method for preparing the same PORTON FINE CHEMICALS LTD. (CN) 2015-01-13 US disclosed
US-8933269-B2 Rosuvastatin calcium intermediate and method for preparing the same PORTON FINE CHEMICALS LTD. (CN) 2015-01-13 US disclosed
WO-2014128022-A1 CONVENIENT PROCESS FOR THE PREPARATION OF STATINS F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) 2014-08-28 WO disclosed
EP-2557084-B1 ROSUVASTATIN CALCIUM INTERMEDIATE AND PREPARATION METHOD THEREOF PORTON FINE CHEMICALS LTD (CN) 2014-06-18 EP disclosed
EP-2557084-A1 ROSUVASTATIN CALCIUM INTERMEDIATE AND PREPARATION METHOD THEREOF Porton Fine Chemicals Ltd (CN) 2013-02-13 EP disclosed
US-20120310000-A1 ROSUVASTATIN CALCIUM INTERMEDIATE AND METHOD FOR PREPARING THE SAME PORTON FINE CHEMICALS LTD. (CN) 2012-12-06 US disclosed
US-20120310000-A1 ROSUVASTATIN CALCIUM INTERMEDIATE AND METHOD FOR PREPARING THE SAME PORTON FINE CHEMICALS LTD. (CN) 2012-12-06 US disclosed
US-20110009593-A1 Polymeric Bioplastics PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344439-A1 Convenient Process for the Preparation of Statins HMGCR, PCSK9, FDPS ALDH1A1 1160/4885LMNA 709/4885TSHR 3356/4885
US-20120310000-A1 ROSUVASTATIN CALCIUM INTERMEDIATE AND METHOD FOR PREPARING THE SAME ROS1, KCNN2, KCNN4 ALDH1A1 2438/4885LMNA 407/4885TSHR 3934/4885
US-20160200744-A1 CONVENIENT PROCESS FOR THE PREPARATION OF STATINS HMGCR, PCSK9, FDPS ALDH1A1 1160/4885LMNA 709/4885TSHR 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.